Pharmacy
Who compounds and dispenses your medication.
PEPLUX is a telehealth platform, not a pharmacy or drug manufacturer. Medications are compounded and dispensed by independently licensed US compounding pharmacies.
No dispensing pharmacy is named yet. A product’s intake does not open until its pharmacy is named on its product page and on this page, with its state, whether it is a 503A pharmacy or a 503B outsourcing facility, and its license.
Named pharmacies
None named yet.
Product by product
Planned facility type, and who fills it.
Each product is planned for one facility type. The pharmacy column fills in only once a pharmacy is named.
| Product | Planned facility type | Pharmacy |
|---|---|---|
| Sermorelin | 503B outsourcing facility | Not yet named |
| NAD+ | 503A pharmacy | Not yet named |
| Glutathione | 503A pharmacy | Not yet named |
| Methylcobalamin B12 | 503A pharmacy | Not yet named |
| CJC-1295 and Ipamorelin | 503A pharmacy | Not yet named |
| MOTS-c | 503A pharmacy | Not yet named |
| BPC-157 Injection | 503A pharmacy | Not yet named |
| Epitalon | 503A pharmacy | Not yet named |
| Semax | 503A pharmacy | Not yet named |
| Selank | 503A pharmacy | Not yet named |
| AOD-9604 | 503A pharmacy | Not yet named |
| PT-141 | 503A pharmacy | Not yet named |
| GHK-Cu Injection | 503A pharmacy | Not yet named |
| BPC-157 Capsules | 503A pharmacy | Not yet named |
| Topical GHK-Cu | 503A pharmacy | Not yet named |
| Wolverine Stack | 503A pharmacy | Not yet named |
| GLOW Stack | 503A pharmacy | Not yet named |
| KLOW Stack | 503A pharmacy | Not yet named |
| Semax / Selank Injection | 503A pharmacy | Not yet named |
| Kisspeptin Injection | 503A pharmacy | Not yet named |
| DSIP Injection | 503A pharmacy | Not yet named |
Facility types
Two kinds of compounder.
Which kind fills a prescription is not a detail. FDA keeps separate category documents and bulks lists for each, and a substance can be in one and not the other.
503A pharmacy
A 503A pharmacy is licensed by a state board of pharmacy and compounds medication against a prescription for an individual patient.
503B outsourcing facility
A 503B outsourcing facility registers with FDA, is subject to FDA inspection and to current good manufacturing practice requirements, and may compound without a prescription for each patient. Registration with FDA is not FDA approval of the facility or of what it makes.
A compounded product is not FDA-approved, whichever kind of facility makes it. Each product’s status, including the facility type its status allows, is on its status record.